Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 81

1.

Preprocedural three-dimensional planning aids in transcatheter ductal stent placement: A single-center experience.

Chamberlain RC, Ezekian JE, Sturgeon GM, Barker PCA, Hill KD, Fleming GA.

Catheter Cardiovasc Interv. 2019 Dec 18. doi: 10.1002/ccd.28669. [Epub ahead of print]

PMID:
31854085
2.

Diabetes Digital App Technology: Benefits, Challenges, and Recommendations. A Consensus Report by the European Association for the Study of Diabetes (EASD) and the American Diabetes Association (ADA) Diabetes Technology Working Group.

Fleming GA, Petrie JR, Bergenstal RM, Holl RW, Peters AL, Heinemann L.

Diabetes Care. 2020 Jan;43(1):250-260. doi: 10.2337/dci19-0062. Epub 2019 Dec 5. Review.

PMID:
31806649
3.
4.

Hybrid transcatheter pulmonary valve replacement with a SAPIEN S3 valve after pulmonary artery banding via left lateral thoracotomy.

Serfas JD, Turek J, Haney J, Krasuski RA, Fleming GA.

Catheter Cardiovasc Interv. 2019 Nov 7. doi: 10.1002/ccd.28591. [Epub ahead of print]

PMID:
31696653
5.

Estimating radiation exposure during paediatric cardiac catheterisation: a potential for radiation reduction with air gap technique.

Chamberlain RC, Shindhelm AC, Wang C, Fleming GA, Hill KD.

Cardiol Young. 2019 Dec;29(12):1474-1480. doi: 10.1017/S1047951119002506. Epub 2019 Nov 4.

PMID:
31679554
6.

To help aging populations, classify organismal senescence.

Calimport SRG, Bentley BL, Stewart CE, Pawelec G, Scuteri A, Vinciguerra M, Slack C, Chen D, Harries LW, Marchant G, Fleming GA, Conboy M, Antebi A, Small GW, Gil J, Lakatta EG, Richardson A, Rosen C, Nikolich K, Wyss-Coray T, Steinman L, Montine T, de Magalhães JP, Campisi J, Church G.

Science. 2019 Nov 1;366(6465):576-578. doi: 10.1126/science.aay7319. No abstract available.

7.

Routine postprocedure ultrasound increases rate of detection of femoral arterial thrombosis in infants after cardiac catheterization.

Kamyszek RW, Leraas HJ, Nag UP, Olivere LA, Nash AL, Kemeny HR, Kim J, Hill KD, Fleming GA, Jooste EH, Otto J, Tracy ET.

Catheter Cardiovasc Interv. 2019 Mar 1;93(4):652-659. doi: 10.1002/ccd.28009. Epub 2018 Nov 23.

PMID:
30467963
8.

3-Year Outcomes of the Edwards SAPIEN Transcatheter Heart Valve for Conduit Failure in the Pulmonary Position From the COMPASSION Multicenter Clinical Trial.

Kenny D, Rhodes JF, Fleming GA, Kar S, Zahn EM, Vincent J, Shirali GS, Gorelick J, Fogel MA, Fahey JT, Kim DW, Babaliaros VC, Armstrong AK, Hijazi ZM.

JACC Cardiovasc Interv. 2018 Oct 8;11(19):1920-1929. doi: 10.1016/j.jcin.2018.06.001.

9.

Transcatheter Valve Replacement for Right-sided Valve Disease in Congenital Heart Patients.

Gales J, Krasuski RA, Fleming GA.

Prog Cardiovasc Dis. 2018 Sep - Oct;61(3-4):347-359. doi: 10.1016/j.pcad.2018.09.003. Epub 2018 Sep 17. Review.

PMID:
30236750
10.

Variability in radiation dose and image quality: A comparison across fluoroscopy-system vendors, generations of equipment and institutions.

Hill KD, Mann SD, Carboni MP, Doyle TP, Idriss SF, Janssen DF, Nicholson GT, Sathanandam S, Fleming GA.

Catheter Cardiovasc Interv. 2018 Dec 1;92(7):E471-E477. doi: 10.1002/ccd.27793. Epub 2018 Sep 12.

11.

Validation and refinement of the catheterization RISk score for pediatrics (CRISP score): An analysis from the congenital cardiac interventional study consortium.

Hill KD, Du W, Fleming GA, Forbes TJ, Nykanen DG, Reeves J, Du Y, Kobayashi D.

Catheter Cardiovasc Interv. 2019 Jan 1;93(1):97-104. doi: 10.1002/ccd.27837. Epub 2018 Sep 9.

PMID:
30196566
12.

Palliating Premature Infants With Obstructed Total Anomalous Pulmonary Venous Connection via Catheterization.

Chamberlain RC, Hill KD, Fleming GA.

World J Pediatr Congenit Heart Surg. 2018 Aug 22:2150135118782191. doi: 10.1177/2150135118782191. [Epub ahead of print]

PMID:
30134769
13.
14.

Improving the Clinical Value and Utility of CGM Systems: Issues and Recommendations: A Joint Statement of the European Association for the Study of Diabetes and the American Diabetes Association Diabetes Technology Working Group.

Petrie JR, Peters AL, Bergenstal RM, Holl RW, Fleming GA, Heinemann L.

Diabetes Care. 2017 Dec;40(12):1614-1621. doi: 10.2337/dci17-0043. Epub 2017 Oct 25. Review.

PMID:
29070577
15.

Improving the clinical value and utility of CGM systems: issues and recommendations : A joint statement of the European Association for the Study of Diabetes and the American Diabetes Association Diabetes Technology Working Group.

Petrie JR, Peters AL, Bergenstal RM, Holl RW, Fleming GA, Heinemann L.

Diabetologia. 2017 Dec;60(12):2319-2328. doi: 10.1007/s00125-017-4463-4. Epub 2017 Oct 25. Review.

PMID:
29067486
16.

Utilizing Hybrid Techniques to Maximize Clinical Outcomes in Congenital Heart Disease.

Bearl DW, Fleming GA.

Curr Cardiol Rep. 2017 Aug;19(8):72. doi: 10.1007/s11886-017-0878-2. Review.

PMID:
28667405
17.

Response to Comment on Cefalu et al. Update and Next Steps for Real-World Translation of Interventions for Type 2 Diabetes Prevention: Reflections From a Diabetes Care Editors' Expert Forum. Diabetes Care 2016;39:1186-1201.

Cefalu WT, Buse JB, Tuomilehto J, Fleming GA, Ferrannini E, Gerstein HC, Bennett PH, Ramachandran A, Raz I, Rosenstock J, Kahn SE.

Diabetes Care. 2017 Feb;40(2):e23-e24. doi: 10.2337/dci16-0036. No abstract available.

18.

Post-market surveillance to detect adverse events associated with Melody® valve implantation.

Hill KD, Goldstein BH, Angtuaco MJ, Chu PY, Fleming GA.

Cardiol Young. 2017 Aug;27(6):1090-1097. doi: 10.1017/S1047951116002092. Epub 2016 Nov 10. Review.

19.

The impact of femoral arterial thrombosis in paediatric cardiac catheterisation: a national study.

Kim J, Sun Z, Benrashid E, Southerland KW, Lawson JH, Fleming GA, Hill KD, Tracy ET.

Cardiol Young. 2017 Jul;27(5):912-917. doi: 10.1017/S104795111600161X. Epub 2016 Nov 8.

PMID:
27821192
20.

Update and Next Steps for Real-World Translation of Interventions for Type 2 Diabetes Prevention: Reflections From a Diabetes Care Editors' Expert Forum.

Cefalu WT, Buse JB, Tuomilehto J, Fleming GA, Ferrannini E, Gerstein HC, Bennett PH, Ramachandran A, Raz I, Rosenstock J, Kahn SE.

Diabetes Care. 2016 Jul;39(7):1186-201. doi: 10.2337/dc16-0873. Epub 2016 Jun 9. Review.

21.

Impact of imaging approach on radiation dose and associated cancer risk in children undergoing cardiac catheterization.

Hill KD, Wang C, Einstein AJ, Januzis N, Nguyen G, Li JS, Fleming GA, Yoshizumi TK.

Catheter Cardiovasc Interv. 2017 Apr;89(5):888-897. doi: 10.1002/ccd.26630. Epub 2016 Jun 17.

22.

Corrigendum to "Metformin-associated lactic acidosis: Current perspectives on causes and risk" [Metabolism 65 (2016) 20-29].

DeFronzo R, Fleming GA, Chen K, Bicsak TA.

Metabolism. 2016 Sep;65(9):1432-1433. doi: 10.1016/j.metabol.2016.05.014. Epub 2016 Jun 14. No abstract available.

23.

Maladaptive aortic properties after the Norwood procedure: An angiographic analysis of the Pediatric Heart Network Single Ventricle Reconstruction Trial.

Plummer ST, Hornik CP, Baker H, Fleming GA, Foerster S, Ferguson ME, Glatz AC, Hirsch R, Jacobs JP, Lee KJ, Lewis AB, Li JS, Martin M, Porras D, Radtke WA, Rhodes JF, Vincent JA, Zampi JD, Hill KD.

J Thorac Cardiovasc Surg. 2016 Aug;152(2):471-479.e3. doi: 10.1016/j.jtcvs.2016.03.091. Epub 2016 Apr 14.

24.

Addressing Unmet Medical Needs in Type 1 Diabetes: A Review of Drugs Under Development.

Mittermayer F, Caveney E, De Oliveira C, Fleming GA, Gourgiotis L, Puri M, Tai LJ, Turner JR.

Curr Diabetes Rev. 2017;13(3):300-314. doi: 10.2174/1573399812666160413115655. Review.

25.

Metformin-associated lactic acidosis: Current perspectives on causes and risk.

DeFronzo R, Fleming GA, Chen K, Bicsak TA.

Metabolism. 2016 Feb;65(2):20-9. doi: 10.1016/j.metabol.2015.10.014. Epub 2015 Oct 9. Review.

26.

Coarctation of the aorta: Management from infancy to adulthood.

Torok RD, Campbell MJ, Fleming GA, Hill KD.

World J Cardiol. 2015 Nov 26;7(11):765-75. doi: 10.4330/wjc.v7.i11.765. Review.

27.

CRISP: Catheterization RISk score for Pediatrics: A Report from the Congenital Cardiac Interventional Study Consortium (CCISC).

Nykanen DG, Forbes TJ, Du W, Divekar AA, Reeves JH, Hagler DJ, Fagan TE, Pedra CA, Fleming GA, Khan DM, Javois AJ, Gruenstein DH, Qureshi SA, Moore PM, Wax DH; Congenital Cardiac Interventional Study Consortium (CCISC).

Catheter Cardiovasc Interv. 2016 Feb 1;87(2):302-9. doi: 10.1002/ccd.26300. Epub 2015 Nov 3.

PMID:
26527119
28.

Alternate approaches for pediatric type 1 diabetes drug development and potential regulatory approval: a perspective.

Turner JR, Close KL, Fleming GA, Wherrett DK, DiMeglio LA.

Diabetes Care. 2015 Oct;38(10):1986-91. doi: 10.2337/dc14-2707.

PMID:
26404928
29.

Transcatheter pulmonary embolectomy after fontan.

Torok RD, Fleming GA, Hill KD.

Catheter Cardiovasc Interv. 2016 Apr;87(5):939-44. doi: 10.1002/ccd.26096. Epub 2015 Jul 8.

30.
32.

Sildenafil exposure and hemodynamic effect after Fontan surgery.

Tunks RD, Barker PC, Benjamin DK Jr, Cohen-Wolkowiez M, Fleming GA, Laughon M, Li JS, Hill KD.

Pediatr Crit Care Med. 2014 Jan;15(1):28-34. doi: 10.1097/PCC.0000000000000007.

33.

Intervention for recoarctation in the single ventricle reconstruction trial: incidence, risk, and outcomes.

Hill KD, Rhodes JF, Aiyagari R, Baker GH, Bergersen L, Chai PJ, Fleming GA, Fudge JC, Gillespie MJ, Gray RG, Hirsch R, Lee KJ, Li JS, Ohye RG, Oster ME, Pasquali SK, Pelech AN, Radtke WA, Takao CM, Vincent JA, Hornik CP.

Circulation. 2013 Aug 27;128(9):954-61. doi: 10.1161/CIRCULATIONAHA.112.000488. Epub 2013 Jul 17.

34.

Sildenafil exposure and hemodynamic effect after stage II single-ventricle surgery.

Hill KD, Tunks RD, Barker PC, Benjamin DK Jr, Cohen-Wolkowiez M, Fleming GA, Laughon M, Li JS.

Pediatr Crit Care Med. 2013 Jul;14(6):593-600. doi: 10.1097/PCC.0b013e31828aa5ee.

35.

A strategy for atrial septal defect closure in small children that eliminates long-term wall erosion risk.

Hill KD, Lodge AJ, Forsha D, Fleming GA, Green AS, Rhodes JF.

Catheter Cardiovasc Interv. 2013 Mar;81(4):654-9. doi: 10.1002/ccd.24500. Epub 2012 Nov 14.

PMID:
22639441
36.

Counterpoint--the end point: less is more.

Fleming GA.

J Diabetes Sci Technol. 2011 Sep 1;5(5):1290-3.

37.

Angiotensin-converting enzyme inhibition alters the inflammatory and fibrinolytic response to cardiopulmonary bypass in children.

Fleming GA, Billings FT 4th, Klein TM, Bichell DP, Christian KG, Pretorius M.

Pediatr Crit Care Med. 2011 Sep;12(5):532-8. doi: 10.1097/PCC.0b013e3181fe3925.

38.

Angiojet rheolytic thrombectomy in infants following cardiac surgery.

Fleming GA, Khan M, Janssen D, Doyle T.

Catheter Cardiovasc Interv. 2010 Aug 1;76(2):233-40. doi: 10.1002/ccd.22544.

PMID:
20665869
39.

Glutamic Acid decarboxylase therapy for recent-onset type 1 diabetes: are we at the end or the beginning of finding a cure?

Fleming GA, Klonoff DC.

J Diabetes Sci Technol. 2009 Mar 1;3(2):215-8. No abstract available.

40.

Challenges in developing endpoints for type 1 diabetes intervention studies.

Cernea S, Raz I, Herold KC, Hirshberg B, Roep BO, Schatz DA, Fleming GA, Pozzilli P, Little R, Schloot NC, Leslie RD, Skyler JS, Palmer JP; D-Cure Workshop.

Diabetes Metab Res Rev. 2009 Nov;25(8):694-704. doi: 10.1002/dmrr.1002. Review.

PMID:
19771545
41.

Milrinone use is associated with postoperative atrial fibrillation after cardiac surgery.

Fleming GA, Murray KT, Yu C, Byrne JG, Greelish JP, Petracek MR, Hoff SJ, Ball SK, Brown NJ, Pretorius M.

Circulation. 2008 Oct 14;118(16):1619-25. doi: 10.1161/CIRCULATIONAHA.108.790162. Epub 2008 Sep 29.

42.

The cerebroplacental Doppler ratio predicts postnatal outcome in fetuses with congenital heart block.

Fleming GA, Bircher A, Kavanaugh-McHugh A, Liske MR.

J Perinatol. 2008 Dec;28(12):791-6. doi: 10.1038/jp.2008.105. Epub 2008 Aug 14.

PMID:
18704034
43.

A case of an infant with flail tricuspid valve due to spontaneous papillary muscle rupture: was neonatal lupus the culprit?

Fleming GA, Scholl FG, Kavanaugh-McHugh A, Liske MR.

Pediatr Cardiol. 2008 Mar;29(2):442-5. Epub 2007 Sep 20.

PMID:
17882476
44.

Practitioners' views.

Fleming GA.

Vet Rec. 2006 Sep 9;159(11):368. No abstract available.

PMID:
16963724
45.

A cord blood transplant recipient with Mycobacterium mucogenicum central venous catheter infection after infusion of tap water.

Fleming GA, Frangoul H, Dermody TS, Halasa N.

Pediatr Infect Dis J. 2006 Jun;25(6):567-9.

PMID:
16732163
46.

C-peptide is the appropriate outcome measure for type 1 diabetes clinical trials to preserve beta-cell function: report of an ADA workshop, 21-22 October 2001.

Palmer JP, Fleming GA, Greenbaum CJ, Herold KC, Jansa LD, Kolb H, Lachin JM, Polonsky KS, Pozzilli P, Skyler JS, Steffes MW.

Diabetes. 2004 Jan;53(1):250-64. Erratum in: Diabetes. 2004 Jul;53(7):1934.

47.

The FDA, regulation, and the risk of stroke.

Fleming GA.

N Engl J Med. 2000 Dec 21;343(25):1886-7. No abstract available.

PMID:
11117982
48.

Lactic acidosis in patients with diabetes treated with metformin.

Misbin RI, Green L, Stadel BV, Gueriguian JL, Gubbi A, Fleming GA.

N Engl J Med. 1998 Jan 22;338(4):265-6. No abstract available.

PMID:
9441244
49.

How do you get experience?. Interview by Barbara J. Linney.

O'Malley JE, Sanders JR, Saxton NL, FLeming GA, Ellis RS.

Physician Exec. 1996 Oct;22(10):48-9. No abstract available.

PMID:
10162495
50.

Reengineering the medical staff. Thirteen equals two.

Fleming GA.

Physician Exec. 1996 Sep;22(9):35-8.

PMID:
10161952

Supplemental Content

Loading ...
Support Center